GT200600271A - Moduladores no esterides de receptores de progesterona - Google Patents

Moduladores no esterides de receptores de progesterona

Info

Publication number
GT200600271A
GT200600271A GT200600271A GT200600271A GT200600271A GT 200600271 A GT200600271 A GT 200600271A GT 200600271 A GT200600271 A GT 200600271A GT 200600271 A GT200600271 A GT 200600271A GT 200600271 A GT200600271 A GT 200600271A
Authority
GT
Guatemala
Prior art keywords
modulators
esterid
progesterone receptors
therapy
prevention
Prior art date
Application number
GT200600271A
Other languages
English (en)
Spanish (es)
Inventor
Ulrich Bothe
Peter Droescher
Ulrike Fuhrmann
Alexander Hillisch
Guenter Kaufmann
Carsten Moller
Norbert Schmees
Wolfgang Schwede
Lothar Sobek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200600271A publication Critical patent/GT200600271A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/02—1,2-Oxazines; Hydrogenated 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GT200600271A 2005-06-24 2006-06-28 Moduladores no esterides de receptores de progesterona GT200600271A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005030292A DE102005030292A1 (de) 2005-06-24 2005-06-24 Nichtsteroidale Progesteronrezeptor-Modulatoren

Publications (1)

Publication Number Publication Date
GT200600271A true GT200600271A (es) 2007-02-05

Family

ID=37199176

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600271A GT200600271A (es) 2005-06-24 2006-06-28 Moduladores no esterides de receptores de progesterona

Country Status (22)

Country Link
EP (1) EP1902049A2 (no)
JP (1) JP2008543910A (no)
KR (1) KR20080030622A (no)
CN (1) CN101248066A (no)
AR (1) AR054519A1 (no)
AU (1) AU2006261048A1 (no)
BR (1) BRPI0611903A2 (no)
CA (1) CA2611897A1 (no)
CR (1) CR9598A (no)
DE (1) DE102005030292A1 (no)
DO (1) DOP2006000148A (no)
EA (1) EA200702524A1 (no)
EC (1) ECSP078044A (no)
GT (1) GT200600271A (no)
IL (1) IL188021A0 (no)
MX (1) MX2008000072A (no)
NO (1) NO20080440L (no)
PE (1) PE20070125A1 (no)
TW (1) TW200740778A (no)
UY (1) UY29624A1 (no)
WO (1) WO2006136461A2 (no)
ZA (1) ZA200800690B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (es) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag Moduladores no esteroides de receptores de progesterona
DE102007032800A1 (de) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007058747A1 (de) 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
JP2011519916A (ja) * 2008-07-02 2011-07-14 ファーマコステック カンパニー リミテッド アミド誘導体の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19856475A1 (de) * 1998-11-27 2000-05-31 Schering Ag Nichtsteroidale Entzündungshemmer
EP1344776A1 (en) * 2002-03-11 2003-09-17 Schering Aktiengesellschaft 5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
JP2008529963A (ja) * 2003-07-01 2008-08-07 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 複素環式−置換されたペンタノール誘導体類、それらの生成方法及び抗炎症剤としてのそれらの使用

Also Published As

Publication number Publication date
KR20080030622A (ko) 2008-04-04
DOP2006000148A (es) 2007-07-15
EA200702524A1 (ru) 2008-06-30
JP2008543910A (ja) 2008-12-04
CR9598A (es) 2008-04-09
EP1902049A2 (en) 2008-03-26
ZA200800690B (en) 2009-09-30
ECSP078044A (es) 2008-01-23
BRPI0611903A2 (pt) 2010-10-05
IL188021A0 (en) 2008-03-20
AU2006261048A1 (en) 2006-12-28
WO2006136461A2 (en) 2006-12-28
WO2006136461A3 (en) 2007-03-15
CN101248066A (zh) 2008-08-20
CA2611897A1 (en) 2006-12-28
TW200740778A (en) 2007-11-01
NO20080440L (no) 2008-03-25
DE102005030292A1 (de) 2007-01-11
PE20070125A1 (es) 2007-02-14
UY29624A1 (es) 2007-01-31
MX2008000072A (es) 2008-03-24
AR054519A1 (es) 2007-06-27

Similar Documents

Publication Publication Date Title
CR10489A (es) Derivados fenil-pirazol como ligandos de receptores glucocorticoides no esteroides
CU20120175A7 (es) Compuestos derivados de 6,7-dihidro-5h-benzo[7]anulenos
ECSP18047708A (es) Derivados de 17-hidroxi-17-pentafluoroetil-estra-4,9(10)-dien-11-arilo como antagonistas de progesterona y procedimientos para su preparación
SV2010003580A (es) Agonistas novedosos de los receptores de glucocorticoides
CR10875A (es) Derivados de ester y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides
PA8780201A1 (es) Derivados de pirasol sustituidos con heteroaril utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis
ECSP099620A (es) Derivados de ciclohexano espirociclico
CL2011000544A1 (es) Compuestos derivados de benzamida n sustituida por heterociclo, ligandos de los receptores cannabinoides; composicion farmaceutica; y su uso para tratar el dolor, entre otras enfermedades.
UY30572A1 (es) N-(1-ftalazin-1-il-piperidin-4-il)-amidas como moduladores del receptor ep2
UY29626A1 (es) Moduladores no esteroides de receptores de progesterona
GT200600271A (es) Moduladores no esterides de receptores de progesterona
GT200600335A (es) Moduladores del receptor de progesterona cianopirrol-fenil amida y usos de los mismos
UY29625A1 (es) Uso de moduladores no esteroides de receptores de progesterona
UY31143A1 (es) Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas
CL2015003014A1 (es) Composición farmacéutica que comprende 0,5-5 mg de (11?,17?)-17-hidroxi-11-[4-(metilsulfonil)fenil]-17-(pentafluoroetil)estra-4,9-dien-3-ona; forma de dosificación oral; uso para tratar y/o prevenir una enfermedad ginecológica, tal como, fibroides en el útero, endometriosis o hemorragias menstruales excesivas.
UY30815A1 (es) Moduladores no esteroidales del receptor de progesterona
UY30805A1 (es) Moduladores no esteroides de receptores de progesterona
CL2007003723A1 (es) Compuestos ciclicos o heterociclicos sustituidos, moduladores no esteroidales del receptor de progesterona; composicion farmaceutica; y uso para tratar y/o prevenir enfermedades ginecologicas tal como endometriosis y dismenorrea, tumores dependientes
BRPI0813158A2 (pt) Composto, compósição contraceptiva, composição farmacêutica, uso de um composto, e, métodos de contracepção, de terapia de reposição hormonal, e de tratamento um distúrbio ginecológico
CR7609A (es) Uso de derivados de tio-oxindol en tratamiento de trastornos de la piel
TH85615A (th) สารปรับโพรเจสเตอโรนรีเซปเตอร์ชนิดนอนสเตียรอยด์
TH85615B (th) สารปรับโพรเจสเตอโรนรีเซปเตอร์ชนิดนอนสเตียรอยด์
TH163150A (th) รูปแบบยาของโพรเจสเทอโรนรีเซปเตอร์แอนตะกอนิสต์
CU20090109A7 (es) Derivados de éster y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides